๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease

โœ Scribed by Anthony H. V. Schapira; C. Warren Olanow


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
112 KB
Volume
53
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Comparison between the decrease of dopam
โœ Yasushi Ito; Masahiro Fujita; Shoichi Shimada; Yoshiyuki Watanabe; Tomoya Okada; ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 122 KB ๐Ÿ‘ 1 views

Early diagnosis of Parkinson's disease (PD) is important for the potential application of neuroprotective therapies. The purpose of this study was to assess the detection of the early changes of PD by either imaging the dopamine transporter (DAT) or uptake of L-3,4-dihydroxyphenylalanine (L-DOPA). A